ReviewFrontiers in pharmacology2023

Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies.

Braden Millar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.